Parofor Crypto

1 x 125 ml

Oral solution

Active substance

Paromomycin (Paromomycin sulfate) : 140.000 IU/ml

ATC code

QA07AA06 Paromomycin

QA07AA Antibiotics

QA07A Intestinal antiinfectives

QA07 Antidiarrheals, intestinal anti-inflammatory / anti-infective agents

QA Alimentary tract and metabolism

Species

Sheep (pre-ruminant) and goats (pre-ruminant).

Indications

Reduction of the severity and the duration of diarrhoea associated with Cryptosporidium parvum in individual animals confirmed to have cryptosporidial oocysts in their faeces.

Paromomycin reduces faecal oocyst shedding.

Dose to be administered and administration route

For oral use.

Dose rate: 35 000 IU of paromomycin /kg BW /day for 7 consecutive days, i.e.

0.25 ml of veterinary medicinal product / 1 kg BW/day for 7 consecutive days. The consecutive treatment should be done at the same time each day. To ensure a correct dosage, bodyweight should be determined as accurately as possible and the use of either a syringe or any appropriate device for oral administration is necessary.

Only a single course of treatment should be administered to an individual animal.

Adverse reactions

Sheep and goats:

Undetermined frequency (cannot be estimated from available data)

Nephropathy (nephrotoxicity) ¹

Internal ear disorder

(ototoxicity)¹

¹can be caused by aminoglycoside antibiotics such as paromomycin

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.